Paul Hastings LLP represented Caladrius Biosciences, Inc., (CLBS) a NASDAQ-listed clinical stage development company with a cell therapy pipeline focused on immune modulation and select cardiovascular…
Hitachi Chemical Co. America, Ltd.’s Acquisition of Caladrius Biosciences, Inc.’s TPC
![](https://globallegalchronicle.com/wp-content/uploads/2017/06/b079e4efd0.jpeg)